Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
about
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratificationCarbapenems: past, present, and futurePremature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in IndiaElucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic DataEfflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in BrazilMULTILOCUS SEQUENCE TYPING OF CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA ISOLATES FROM PATIENTS PRESENTING AT PORT ELIZABETH HOSPITALS, SOUTH AFRICA.Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in KarachiBeyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesThe resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityOverexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.Pseudomonas aeruginosa: resistance to the maxModification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon.OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosaThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospitalEpidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria.Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosaAlterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.Unforeseeable presentation of Chryseobacterium indologenes infection in a paediatric patient.Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan.Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.ISPpu22, a novel insertion sequence in the oprD porin gene of a carbapenem-resistant Pseudomonas aeruginosa isolate from a burn patient in Tehran, IranPrevalence of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa from a Tertiary Level Intensive Care Unit.Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.Bloodstream infections caused by Pseudomonas spp.: how to detect carbapenemase producers directly from blood cultures.Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients.Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.Detection of AmpC-β-lactamases producing isolates among carbapenem resistant P. aeruginosa isolated from burn patient.The resistance and transmission mechanism of Acinetobacter baumannii isolates in a tertiary care hospital, China.Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program).Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.Group IIC intron with an unusual target of integration in Enterobacter cloacaeMechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-β-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil.Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems.
P2860
Q24615937-6CDF5E47-B03B-4F8B-BAC7-FBFCBD7A4B35Q24634999-E1114BB9-2C15-43D5-8623-4D1AD0EBAC60Q28550102-334D1924-8328-4AF1-A5C8-1212DD55976DQ31073879-44606A4A-5442-4FFD-9A4C-8A41CFAA82BCQ33655586-55EE37BB-81F7-4C59-BF4D-594CF8E1F206Q33813460-1C680AAB-94D4-491B-8A61-B717F99DCF5DQ34176098-441AB529-7208-4588-B7AF-C9DEB67BC08FQ34266074-D95ED4A9-AC4D-4F0E-AB58-44CB3A7555C7Q34922676-4DF33928-CB52-4A2B-85DB-756592D08DC1Q34932869-8369BA06-1FC4-4E8B-A3E2-6CBE5965307AQ35084559-2D4EA7A1-A33A-4803-B6F2-257D659EB7FAQ35203279-ED622509-99BA-4A94-8066-7CED3F8E7D54Q35270559-6E8D5430-4991-47C7-813C-096DD2E9BF8AQ35482558-396363BF-3BE5-4589-BE2F-9E0C9C8804F5Q35570372-453BDE87-621D-48B7-A1B5-2236E1519D0BQ35689071-74D3BE2C-E313-4281-8B17-604E9C3F0B56Q35734019-2496C305-BEDC-4CDA-A503-9C24A2A5EDE6Q35806387-4184618D-783D-46BB-A281-D6BF147A26A5Q35867439-F079E999-39CB-4C53-9496-B59B6E3B78BBQ35867456-DE3278C7-092D-4471-8863-AC09591B6D58Q35986561-B0743C4E-9530-45C9-8111-6046D802A06EQ36050858-68078EBC-80F4-409D-997D-15505D8AE01DQ36075893-2BEDCAB3-DBC6-4D25-B9FD-5CCEA801EFDEQ36415463-DD5EA2E9-D9D9-4EC1-815E-60118C84393EQ37449612-95864FF0-6F9C-4FF5-A2CE-19BA16594E95Q37894832-0C6E16A1-F912-4946-A87C-26BD205BDFADQ38751264-768DC4D4-CD44-4B8E-9CE2-5F2C805F6FA1Q38833703-86068967-550D-4C75-8EBC-CDB22ACB1808Q38853962-D44A4DC0-1BDB-4E02-AD59-2BD766754144Q39071995-B1802B63-4151-471B-BF76-5EDFBE95E85BQ39183212-473E3001-5753-4A10-83C3-703007AC4941Q39237831-17720401-FA8D-45C7-96BA-407EA37C4859Q39851375-247B2865-C473-4ED2-AFDB-A12C77C5A9BDQ40166144-150A30BA-A899-4A4F-B51F-D24D984E86D6Q40266214-D0051F0D-5027-49FD-90F7-0F8F190DA78CQ40287334-8B7F24E7-0B6A-4033-9DEC-E7360BBF61E4Q40306198-FA8AD008-AF69-43DD-A69D-622C36F348AAQ40345702-20EED640-FD5D-4924-890F-37D9E527FC2AQ40532502-04026D92-286E-45C1-BCCF-EA4899578AFCQ40540884-0D50EF6A-BFF0-4D22-A035-4E0585732504
P2860
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@en
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@nl
type
label
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@en
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@nl
prefLabel
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@en
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@nl
P2860
P356
P1476
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
@en
P2093
José-Manuel Rodríguez-Martínez
P2860
P304
P356
10.1128/AAC.00574-09
P407
P577
2009-09-08T00:00:00Z